This biotech is working on a GLP-1 pill that could be better than the Wegovy version
This experimental pill helped people lose about 16% of their body weight after about a year of treatment
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
Bitcoin bulls avoided a correction as US markets opened, but analysis warned that Strategy was responsible for much of the latest BTC price strength.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse ArticlesThis experimental pill helped people lose about 16% of their body weight after about a year of treatment
"The issue is not the weather, high insurance premiums or high maintenance fees."
QuantumScape is on a mission to significantly improve battery technology, but it still has its work cut out for it.
Senator Angela Alsobrooks says she's working on a proposal to move a key crypto bill forward, but crypto and the banks will have to compromise.
Americans are opting out of the Affordable Care Act, and health insurance companies are taking a financial hit.
Without privacy, the industry is fundamentally mismatched with its audience and stalling mass adoption, argues Gruell.
For the next three months, investors should consider cutting their exposure to stocks, increase their holdings of cash, and use call options to benefit fro...
Bybit Alpha Officially Integrates Mantle Chain, Expanding Multi-Chain Ecosystem and Asset Diversity
Vinay Prasad, an official for the Food and Drug Administration, is reportedly stepping down, which is welcome news for biotech companies.
Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with th...
Roche shares drop 5% as breast cancer drug giredestrant fails clinical trial
After a bumpy year for the electric vehicle industry, there's a bit of good news for Lucid specifically.